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Abstract
Background: We hypothesized that gp91
phox (NOX2), a subunit of NADPH oxidase, generates superoxide anion
(O2
-) and has a major causative role in traumatic brain injury (TBI). To evaluate the functional role of gp91
phox and
reactive oxygen species (ROS) on TBI, we carried out controlled cortical impact in gp91
phox knockout mice
(gp91
phox-/-). We also used a microglial cell line to determine the activated cell phenotype that contributes to
gp91
phox generation.
Methods: Unilateral TBI was induced in gp91
phox-/- and wild-type (Wt) mice (C57/B6J) (25-30 g). The expression
and roles of gp91
phox after TBI were investigated using immunoblotting and staining techniques. Levels of O2
- and
peroxynitrite were determined in situ in the mouse brain. The activated phenotype in microglia that expressed
gp91
phox was determined in a microglial cell line, BV-2, in the presence of IFNg or IL-4.
Results: Gp91
phox expression increased mainly in amoeboid-shaped microglial cells of the ipsilateral hemisphere of
Wt mice after TBI. The contusion area, number of TUNEL-positive cells, and amount of O2
- and peroxynitrite
metabolites produced were less in gp91
phox-/- mice than in Wt. In the presence of IFNg, BV-2 cells had increased
inducible nitric oxide synthase and nitric oxide levels, consistent with a classical activated phenotype, and
drastically increased expression of gp91
phox.
Conclusions: Classical activated microglia promote ROS formation through gp91
phox and have an important role in
brain damage following TBI. Modulating gp91
phox and gp91
phox -derived ROS may provide a new therapeutic
strategy in combating post-traumatic brain injury.
Background
Traumatic brain injury (TBI) is a serious condition in
emergency medicine, and its pathophysiological profile
is varied and complicated. One of the neurotoxic factors
thought to be involved is oxidative stress [1,2]. A large
number of studies have reported that oxidative stress,
which generates reactive oxygen species (ROS), plays a
key role in the development of TBI [1,3,4]. Conse-
quently, one of the most obvious ways to manage TBI
may be to control ROS generation [1] given that animal
experiments have supported the notion that free radical
scavengers and antioxidants dramatically reduce cerebral
damage [1,5,6]. The superoxide anion (O2
-) is an impor-
tant free radical, and is the source of other ROS that
lead to lipid peroxidation [7]. Cyclooxygenase, xanthine
oxidase, and NADPH oxidases of the NOX family are
well known generators of O2
- in the brain. However, the
main cellular mediator of O2
- generation after TBI has
not yet been determined. NADPH oxidase, a multiunit
enzyme initially discovered in neutrophils, has recently
emerged as a major generator of ROS in neurons, glial
cells and cerebral blood vessels [8-10]. NADPH oxidase
is composed of membrane-bound (p22
phox and
gp91
phox) and cytoplasmic subunits (p40
phox,p 4 7
phox,
and p67
phox). Several homologs of the catalytic subunit
of the enzyme, gp91
phox, also termed NOX2, exist
(NOX1 through NOX5) [11,12]. It has been reported
that gp91
phox-containing NADPH oxidase produces a
large amount of O2
- in leukocytes, while numerous
papers have reported on the role for gp91
phox in various
neurodegenerative conditions [13,14]. However, the
source and the roles of gp91
phox after TBI have not
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phox-/-
mouse to investigate the kinetics and the roles of
gp91
phox following TBI.
Methods
Animals
All experimental procedures involving animals were
approved by the Institutional Animal Care and Use
Committee of Showa University. The gp91
phox-/- (C57/
B6J) mice are described by Dinauer et al. [15], Wild
mice (Wt) were generated from the same chimeric foun-
der, and experiments were performed in age- and
weight-matched animals.
Controlled cortical impact model
Mice were anesthetized with 2% sevoflurane in 70%
N2Oa n d3 0 %O 2. A controlled cortical impact was
made using a pneumatically controlled impactor device
as described previously [16].
Cell culture
We used the BV-2 microglial cell line to investigate
which microglia cells express gp91
phox [17]. This mouse
BV-2 cell line was obtained from Interlab Cell Line Col-
lection (Genova, Italy) and cultured in 10% RPMI1640
(RPMI1640 with 10% fetal calf serum [FCS], 100 U/ml
penicillin, 100 μg/ml streptomycin, and 2 mM L-gluta-
mine [all from GIBCO/BRL, Grand Island, NY]). The
cells were grown at 37°C in a humidified 5% CO2 incuba-
tor. After harvesting, the cells were washed with PBS
twice and resuspended with experimental medium (Dul-
becco’s modified Eagle’s medium [GIBCO/BRL] with 1%
FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2
mM L-glutamine). The cells were seeded into six-well
plates at 1 × 10
6 cells/well/ml and then exposed to IFNg
(10 ng/ml), IL-4 (20 ng/ml), IL-10 (10 ng/ml, all from
Peprotech, Rocky Hill, NJ), or vehicle (n = 3/group).
Twenty-four hours later, the cells were collected by cen-
trifugation. The samples were kept at -30°C until analysis.
Western blot analysis
The cerebrum was removed from decapitated animals at
0 (sham-operated), 24, and 48 hours after TBI and
divided into the ipsilateral and contralateral hemi-
spheres. These samples were then homogenized in lysis
buffer (10 mM Tris-HCl [pH 7.4], 0.15 M NaCl and 1%
Triton X-100, 1 mM EGTA, 50 mM NaF, 2 mM sodium
orthovanadate, 10 mM sodium pyrvate, and protease
inhibitor cocktail [Sigma, St. Louis, MO]), and centri-
fuged at 12,000 × g for 10 minutes on ice. BV-2 samples
were sonicated for 10 seconds with lysis buffer to pre-
pare cell suspensions.
After determination of the protein concentration (BCA
protein assay, Thermo Fisher Scientific, Waltham, MA),
appropriate amounts of samples were electrophoresed.
The separated proteins were then transferred to polyviny-
lidinene fluoride membranes (Bio-Rad, Hercules, CA).
After blocking with 2% Blockace (DS Pharma, Osaka,
Japan), the membranes were probed with primary antibo-
dies. After washing, the membrane was probed with
horseradish peroxidase (HRP)-conjugated secondary anti-
bodies. The protein bands were detected by chemilumi-
nescence (SuperSignal West Dura Extended Duration
Substrate; Pierce, Rockford, IL) and exposed onto X-ray
film. The films were scanned, and the signal densities
were quantified using the UN-SCAN-IT gel analysis
program (Silk Scientific, Orem, UT).
Immunohistochemistry
Mice subjected to TBI were placed under pentobarbital
(50 mg/kg, i.p.) anesthesia and perfused with 0.9% NaCl
followed by 2% paraformaldehyde (PFA). Brains were
removed and processed to frozen blocks that were then
cut into 8-μm sections (n = 4-5/group).
The sections were incubated with 0.3% H2O2 and then
incubated with PBS containing 5% normal horse serum
to mask nonspecific reactions. Next, the sections were
incubated with antibody raised against gp91
phox [18].
O n ed a yl a t e r ,t h es e c t i o n sw e r er i n s e da n di n c u b a t e d
with biotinylated goat anti-rabbit IgG (Santa Cruz
Biotechnology, Santa Cruz, CA), and then with an avi-
din-biotin complex solution (Vector Laboratories,
Burlingame, CA) followed by diaminobenzidine (DAB;
Vector) as a chromogen.
A similar procedure was used for multiple immunos-
taining, except that the sections were not incubated
with 0.3% H2O2, and were incubated with Alexa-labeled
fluorescence secondary antibodies. Primary and second-
ary antibodies for multiple-staining are listed in Table 1.
4,6-Diamidine-2-phenylindole dihydrochloride (DAPI,
1:10,000; Roche, Mannheim, Germany) was used for
nuclear staining. The fluorescence and immunolabeling
were detected using a confocal laser microscope (AX-10,
Zeiss; Oberkochen, Germany).
Evaluation of the injured brain area
The areas of injured brain were determined using 2,3,5-
triphenyltetrazolium chloride (TTC) staining of tissues
48 hours after TBI. The animals were decapitated, and
the brain was sectioned into four 2-mm coronal sections
by using a mouse brain matrix. The brain slices were
then stained with 2% TTC at 37°C for 30 min and
photographed on the anterior surface of each section
with a scale bar. The areas of injured brain were deli-
neated by examining differences between the ipsilateral
and contralateral regions in the center slice of injured
brain and measured by using NIH Image software.
http://rsb.info.nih.gov/nih-image/about.html.
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To determine neural apoptosis-like cell death, terminal
deoxynucleotidyl transferase-mediated dUTP end-label-
ing (TUNEL) staining (In Situ Cell Death Detection Kit,
POD; Roche) was performed 48 hours after TBI (n =5 )
and the number of TUNEL-positive cells in the ipsilat-
eral hemisphere was then counted and compared
gp91
phox-/- with Wt mice in a similar cortical region
(40 × magnification).
In situ detection of O2
-
Production of O2
- was determined by in situ detection of
oxidized hydroethidium (HEt) [19]. With the animal
placed under anesthesia, the HEt solution was adminis-
tered (1 mg/mL 0.9% NaCl with 1% DMSO) into the
jugular vein (n = 3 per group) 48 hours after TBI. Fifteen
minutes later, the brain was removed and frozen in
blocks and cryosectioned (8 μm) in the coronal plane. To
demonstrate the cellular distribution of Et, the sections
were co-stained with antibodies raised against gp91
phox,
CD11b, GFAP, or NeuN. Fluorescence was detected
using confocal laser microscopy (AX-10, Zeiss, Germany)
NO and TNFa measurement in media
Levels of NO and TNFa production are markers of clas-
sically activated microglia [20]. NO production was mea-
sured using the Griess method (Dojindo, Kumamoto,
Japan) as total NO (NO2
- and NO3
-). TNFa production
was measured by enzyme-linked immunosorbent assay
using the Duoset ELISA Development System (R&D
Systems, Minneapolis, MN).
Assay for arginase activity
Arginase is a marker for alternatively activated microglia
[20]. Arginase activity was measured according to a pre-
vious paper [21] with minor modification. In brief, the
cell homogenate was mixed with equal volumes of pre-
warmed 50 mM Tris-HCl, pH 7.5 containing 10 mM
MnCl2 and incubated for 15 minutes at 55°C. The mix-
ture was incubated in 0.25 M L-arginine for 60 minutes
at 37°C to produce urea from arginine and the reactions
were stopped by adding Stop solution (H2SO4/H3PO4/
H2O, 1:3:7). Then, 1% (final concentration) 1-phenyl-1,
2-propanedione-2-oxime (ISPF) in ethanol was added to
the solution, which was heated at 100°C for 45 min. The
reaction between urea and ISPF produced a pink color,
and absorption was measured at 540 nm.
Statistical analysis
Data are expressed as mean ± SE for in vivo experi-
ments. Data are expressed as mean ± SD for in vitro
experiments Statistical comparisons were performed
using the Student’s t tests and two-way analysis of var-
iance (ANOVA) as appropriate. P values less than 0.05
were considered statistically significant.
Results
Gp91
phox is upregulated in the peri-contusional region
after traumatic brain injury
Fig 1 shows the results of immunoblotting experiments
to describe the expression of gp91
phox after TBI. Protein
levels of gp91
phox were not increased after TBI in the
contralateral hemisphere of Wt mice. In the ipsilateral
Table 1 Antibodies used for immunoblotting (IB) and immunohistochemistry (IHC)
Antibody Antigen Host Company Catalog # Dilution
Primary antibody (clone #)
gp91
phox Human gp91 Rabbit See ref 18 4,000 (IB)
200 (IHC)
p22
phox Human p22 Rabbit See ref 18 3,000
iNOS Mouse iNOS Rabbit Transduction Laboratories (Lexington, KY) N32030 10,000
Ym1 Mouse Ym1 Rabbit StemCell Tech (Vancouver, BC, Canada) 01404 1,000
GAPDH (6C5) Rabbit GAPDH Mouse Chemicon International (Temecula, CA) MAB374 3,000
b-Actin (AC-74) Mouse b-Actin Mouse Sigma (St Louise, MO) A5316 4,000
CD11b (5C6) Mouse CD11b Rat Serotec (Oxford, UK) MCA711 500
GFAP (G-A-5) Mouse GFAP Mouse Sigma (St Louise, MO) G3893 1000
NeuN Mouse NeuN Mouse Chemicon International (Temecula, CA) MAB377 1000
3-NT Nitrated KLH Rabbit Upstate Biotechnology (Lake Placid, NY) 06-284 100
Secondary antibody (conjugation)
Mouse IgG (HRP) Mouse IgG Sheep GE Healthcare Bioscience (Little Chalfont, UK) NA931 2,000
Rabbit IgG (HRP) Rabbit IgG Donkey GE Healthcare Bioscience (Little Chalfont, UK) NA934 3,000
Rabbit IgG (biotinylated) Rabbit IgG Goat Santa Cruz Biotechnology (Santa Cruz, CA) SC-2040 200
Mouse IgG (Alexa 546) Mouse IgG Goat Molecular Probes (Eugene, OR) A11030 400
Rabbit IgG (Alexa 488 or 546) Rabbit IgG Goat Molecular Probes (Eugene, OR) A11034 or 11035 400
Rat IgG (Alexa 546) Rat IgG Goat Molecular Probes (Eugene, OR) A11081 400
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phox were
greater at 1 and 2 days after TBI relative to the contral-
ateral hemisphere (Fig 1A, B). The data indicate that
gp91
phox increased in the ipsilateral hemisphere follow-
ing TBI stress.
The results of single immunohistochemical detection
of gp91
phox after TBI are presented Fig 2A. Two days
after TBI, gp91
phox immunoreactivity was dramatically
increased in the peri-contusion region.
Gp91
phox is mainly expressed by cytotoxic-type classically
activated microglia in the peri-contusional regions after
TBI
To identify the cell types expressing gp91
phox in the
peri-contusional area, cells were co-labelled with antibo-
dies raised against gp91
phox and markers of microglial
(CD11b), astroglial (GFAP), and neuronal (NeuN) cells
(Fig 2B). The immunoreactivity for gp91
phox was mainly
co-localized to microglia that had amoeboid-like mor-
phological features with round cell body and short pro-
cesses, suggesting cytotoxic-type classical activation.
Immunoreactive staining for gp91
phox was also co-loca-
lized to a few astrocytes and neurons.
Gp91
phox inhibition reduces the severity of TBI in vivo
TTC staining was used to evaluate the role of gp91
phox
on the severity of TBI in gp91
phox-/- and Wt mice
(Fig 3A, B). Images of the TTC-stained anterior surface
of coronal sections demonstrated that the injured brain
area in gp91
phox-/- mice was significantly smaller (P <
0.01) than that of the Wt mice (Fig. 3B). We verified the
prevention of the cortical injury with TUNEL staining,
which was used to identify apoptotic-like cell death at
48 hours after TBI (Fig 3C, D). The number of TUNEL-
positive cells of gp91
phox-/- mice was significantly less
(p < 0.05) compared with Wt mice (Fig 3D).
Gp91
phox gene deletion reduces superoxide radical (O2
-)
production after TBI
High intensity fluorescence staining by the oxidation
product Et was observed, indicating high levels of O2
-
production. The peri-contusional area of Wt mice
accounted for much of the Et signal after TBI (Fig 4A).
Et fluorescence was lower in gp91
phox-/- mice (Fig 4A)
compared to Wt mice (p < 0.05) (Fig 4B). The Et fluor-
escence was associated with p91
phox-positive cells (Fig.
4C), and CD11b-positive microglial cells (Fig. 4D). Some
Figure 1 Characterization of gp91
phox after traumatic brain injury (TBI) using western immunoblots. (A) Immunoblotting signals before
and after TBI in wild-type (Wt) mice (left) and gp91
phox-/- mice (right). (B) In Wt mice, gp91
phox levels were significantly increased on day 1 and
day 2 after TBI (*p < 0.05 relative to sham). Gp91
phox levels on the ipsilateral side were greater than on the contralateral side on day 1 and day 2
after TBI (*p < 0.05). Each value is the mean ± SE (n = 3). Note that the intensity of each sample was quantified and corrected relative to the
labeling control, actin. Increasing levels of gp91
phox were not seen in gp91
phox-/- mice.
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( F i g .4 D ) .T h e s er e s u l t ss u g g e s tt h a tO 2
- is mainly
produced by microglia expressing gp91
phox.
Gp91
phox gene deletion reduces 3-NT generation after TBI
in vivo
Peroxynitrite (ONOO
-) is an oxidant and nitrating agent
and is synthesized by the reaction between O2
- and
nitric oxide (NO). ONOO
- c a nd a m a g eaw i d ea r r a yo f
cellular molecules, including DNA and proteins. 3-NT is
an oxidized metabolite of ONOO
- in vivo.W ep e r -
formed multiple-immunostaining for 3-NT and cell
marker antibodies in the peri-contusional area at
48 hours. Immunoreactivity for 3-NT in Wt mice clearly
co-localized with microglia, astrocytes, and degenerated
neurons (Fig 5; upper panel). In gp91
phox-/- mice,
Figure 2 Expressions and cell identification of gp91
phox in peri-contusional area after traumatic brain injury (TBI). (A) In sham-operated
animals, weak immunoreactivity for gp91
phox was observed in the cortex (upper panel). Two days after TBI, gp91
phox immunoreactivity was
dramatically increased in the peri-contusional area (lower panel). Scale bars = 400 μm. (B) Co-immunostaining of gp91
phox with cell markers in
the peri-contusional region. Immunostaining was carried out using antibodies for gp91
phox (shown in green) together with Integrin alpha M
(CD11b) (upper), glial fibrillary acidic protein (GFAP) (middle), and neuronal nuclear antigen (NeuN) (lower). Microglia, astrocyte, and neuron
markers are shown in red. Gp91
phox immunoreactive cells were co-labeled with all cell markers. Particularly strong expression of gp91
phox was
detected in microglial-like cells (CD11b-positive cells). Cells were counter-stained with DAPI to show nuclei (blue). Scale bars = 20 μm.
Dohi et al. Journal of Neuroinflammation 2010, 7:41
http://www.jneuroinflammation.com/content/7/1/41
Page 5 of 11however, 3-NT immunoreactions were dramatically sup-
pressed in the microglial and astroglial cells (Fig 5).
While 3-NT immunoreactivity was observed in
gp91
phox-/- mouse neurons, the integrity of these cells
was preserved (Fig 5). Taken together these findings
suggest that production of O2
- and ONOO
- by gp91
phox
may influence the severity of TBI.
Classically activated BV-2 increased gp91
phox and p22
phox
From the results presented in Fig. 2 we suggested that
gp91
phox co-localized with classical activated microglia.
We then tried to identify the microglia that expressed
gp91
phox by using the mouse microglial cell line BV-2
and by activating these cells with IFNg,I L - 4 ,o rI L - 1 0 .
As shown in Fig 6, the media from the BV-2 cells
Figure 3 Brain damage and cell death after traumatic brain injury in wild type (Wt) mice and gp91
phox-/- mice. (A) 2,3,5-
triphenyltetrazolium chloride (TTC)-stained coronal brain sections from Wt mice (left) and gp91
phox-/- mice (right) 2 days after TBI. (B) The
contusion area in gp91
phox-/- mice (170.5 ± 71.5 mm
2 ×1 0
-2, n = 20) was significantly smaller than that in the Wt group (290.7 ± 94.0 mm
2 ×
10
-2, n = 10, *p < 0.01, t test). (C) Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-staining in peri-contusional area of wild
type (left) and gp91
phox-/- (right) mice 48 hours after TBI. TUNEL-positive cells numbers in the gp91
phox-/- mice (117 ± 69.3 cells/area, n = 6) were
significantly smaller than those in the Wt group (252 ± 128.9 cells/area, n = 6, *p < 0.05, t test) (D). All values represent the mean ± SE.
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to IFNg, but not to IL-4 or IL-10 at 24 hours. The
IFNg-exposed BV-2 cells had significantly increased
TNFa in their media and expressed iNOS as well. All of
these factors indicate that the BV-2 cells were activated
according to the classically activated phenotype [20]. On
the other hand, the IL-4-exposed BV-2 cells showed
increased arginase activity and levels of Ym-1, indicating
an alternatively activated phenotype [20]. IL-10-exposed
BV-2 cells did not show any changes in levels of these
factors. Immunoblotting experiments showed that
gp91
phox levels increased in the IFNg-exposed BV-2.
Moreover, immunoblotting for a different NADPH oxi-
dase subunit, p22
phox, mirrored that of gp91
phox,s u g -
gesting that not only gp91
phox but also NADPH oxidase
expression was induced in the classically activated
microglia.
Discussions
We demonstrate here that gp91
phox is increased in the
ipsilateral hemisphere after TBI and specifically in
amoeboid-shaped microglial cells. Mice that are gene-
deficient for gp91
phox exhibit reduced primary cortical
damage, as evidenced by reduced areas of contusion,
Figure 4 The roles of gp91
phox in superoxide radical production after traumatic brain injury). (A) Superoxide radical production
(hydroethidium [HEt]-positive cells: shown in red) in the peri-contusional area of wild type (upper) and gp91
phox-/- (lower) mice 2 days after TBI.
(B) TBI-induced superoxide radical production (HEt-positive cells) in the peri-contusional area was significantly attenuated by gp91
phox deficiency
in sham-operated mice, and 2 days after TBI (*p < 0.05, t test). All values represent mean ± SE. (C, D) Co-localization of HEt-positivity with cell
markers in the peri-contusional region. Cell identification was carried out using antibodies for gp91
phox (C), CD11b (D, left), GFAP (D, middle), and
Neu N (D, right) (shown in green). HEt-positive cells were co-localized with gp91
phox-positive cells (C, right, arrows) and microglia-like cells (D,
left, arrows). Although HEt-positive cells were also slightly co-localized with neurons (D, right, arrows), immunoreactivity was lower than for
gp91
phox-positive cells and microglia-like cells. Cells were counter-stained with DAPI to show nuclei (blue). Scale bars = 20 μm (C, D).
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staining. Moreover, we have shown that the gene-defi-
cient mice have lower levels of ROS at the injury site
and widespread oxidative damage after TBI. Finally, we
demonstrate in a BV-2 microglial cell line that gp91
phox
and/or NADPH oxidase are increased in classically acti-
vated microglial cells which are activated by IFNg.
Gp91
phox is expressed constitutively in neurons but
not in glial cells, and O2
- production might play a role
in neuronal homeostasis [22]. However, in neuropatho-
logical conditions including neurodegenerative diseases
and stroke, the gp91
phox-containing NADPH oxidase has
been observed in glial cells, neurons, fibroblasts and vas-
cular endothelial cells, and seems to be involved in ROS
formation [22-29]. Microglial cell gp91
phox appears to be
involved in the induction of neuronal damage in Parkin-
son’s disease, Alzheimer’s disease, and ischemic stroke
[9,14,30,31]. In the present study, we demonstrated that
gp91
phox is mainly expressed in microglia, and at lower
levels in neurons and astrocytes. These microglia exhibit
features of being classically activated. We then demon-
strated that the microglial phenotypes expressed both
gp91
phox and p22
phox, which probably reflects the induc-
tion of NADPH oxidase in the BV-2 mouse microglial
cell line that we used. Our results reveal that NADPH
oxidase is induced in INFg-stimulated, classically acti-
vated microglial cells characterized by increased NO,
iNOS, and TNFa.
In gp91
phox-/- mice, in situ generation of O2
-and an
ONOO
- metabolite, 3-NT, were suppressed in microglia
after TBI. ONOO
- produced by O2
- and NO after TBI
[32] induces oxidative damage, secondary brain damage
and neuroinflammation afterT B I[ 5 , 3 3 ] .W eh a v ev e r i -
fied that TUNEL-positive apoptotic-like cells in the
peri-contusional area and contusion area are suppressed
in gp91
phox-/- mice. These results suggest that gp91
phox
in classically activated microglia-like cells has a harmful
role in primary and secondary brain damage after TBI.
The question of whether microglial cells play harmful
or beneficial roles in CNS injures has been widely
debated and reviewed over several decades [34-36]. The
roles of activated microglia in neuroinflammation are
thought to be complex. Classical activation is induced
by IFNg and is related to the production of proinflam-
matory mediators in the innate immune response.
Another form of activation, called “alternative activa-
tion,” is induced by IL-4 and IL-13 and, compared to
classical activation, does not result in high levels of
expression of proinflammatory mediators such as cyto-
kines and NO. The roles of alternatively activated
microglia during inflammatory process are thought to
involve tissue repair, the production of anti-inflamma-
tory cytokines, fibrosis, and extracellular matrix recon-
struction. Recently, Ohtaki et al. reported that the
injection of human mesenchymal stromal cells protects
against ischemic brain injury by modulating inflamma-
tory and immune responses through the alternative acti-
vation of microglia and/or macrophages [37]. These
studies and our data suggest that controlling microglial
activation and understanding its mechanism and func-
tional significance following TBI may open exciting new
therapeutic avenues.
The suppression of free radical generation and the
scavenging of free radicals after brain damage are
Figure 5 Production and cell identification of peroxynitrite (ONOO
-) in wild type (Wt) (upper) and gp91
phox-/- (lower) mice 48 hours
after TBI. ONOO
- in Wt mice was produced in microglia-like cells (left, arrows), astrocytes (middle, arrows), and degenerated neurons (right,
arrows). In gp91
phox-/- mice, ONOO
- production was strongly suppressed. In neurons, only weak production of ONOO
- was observed, but
degeneration of neurons was not seen (right, arrows). Scale bars = 20 μm.
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supported the notion that free radical scavengers and
antioxidants dramatically reduce TBI [1,6,38]. Excessive
O2
- may produce destructive hydroxyl radicals (OH
-)
and alkoxyl radicals (OR
-) by the iron-catalyzed Haber-
Weiss reaction. The brain is especially prone to radical
damage because it is highly enriched in easily peroxidiz-
able unsaturated fatty acid side chains and iron. Many
studies investigating ischemic injury suggest that inhibi-
tion of NADPH oxidase or gp91
phox is an important
therapeutic target for neuroprotection [39,40]. Some
recent studies have demonstrated that expression of
Figure 6 Expression of gp91
phox and p22
phox in IFNg-exposed classically activated mouse microglial BV-2 cells. BV-2 cells were exposed
to vehicle (vehi), IFNg, IL-4, or IL-10. The levels of microglial phenotype markers (NOx, TNFa, arginase activity, iNOS, and Ym1), gp91
phox, and
p22
phox were evaluated in medium or cell homogenates 24 hours later. Production of (A) NOx and (B) TNFa were determined in the media. (C)
Expression of iNOS, Ym1, gp91
phox, and p22
phox was determined by immunoblotting with reduced samples. ß-Actin levels were used as an
internal control. IFNg-exposed BV-2 cells had increased NOx, TNFa, and iNOS levels, all of which are classical activating markers of the microglial
phenotype. In contrast, IL-4-exposed BV-2 cells had increased arginase activity and Ym1 levels, which are alternative markers of activation.
Gp91
phox and p22
phox levels were increased only in IFNg-exposed BV-2 cells, suggesting induction by classically activated microglial cells.
Dohi et al. Journal of Neuroinflammation 2010, 7:41
http://www.jneuroinflammation.com/content/7/1/41
Page 9 of 11gp91
phox increases in brain after intracerebral hemor-
rhage, resulting in enhanced lipid peroxidation [24,41].
These studies also reported that hemorrhage volume,
brain edema, and neurological function are reduced in
gp91
phox-/- mice, while Lo et al. reported that neurologi-
cal outcomes are improved in gp91
phox-/- mice [42]. On
the other hand, Liu et al. reported that there are no sig-
nificant differences in mortality rate, brain water content
and intensity of oxidative stress between gp91
phox-/- and
wild type mice in a mouse model of subarachnoid
hemorrhage (SAH) [43]. In the present study, we have
shown that, in gp91
phox-/- mice, gp91
phox expressed in
classically-activated microglial-like cells plays a key role
in O2
- production after TBI, and that gp91
phox-derived
O2
- is a key signal for contusion and cell death after
TBI. Our findings indicate that gp91
phox inhibition and
control of microglial classically-activation might provide
a new therapeutic option by suppressing ROS genera-
tion after TBI. However, the indirect influence with TBI
by which ROS production by other NOX families and
i m m u n ec e l l ss u c ha se n d o t h e l i a lc e l lo rl e u k o c y t e si s
currently unclear and will be an important question for
future TBI studies.
Conclusions
In conclusion, we have shown that gp91
phox is expressed
in classical activated microglial-like cells mainly in the
peri-contusional area after TBI. An important generator
of O2
- is gp91
phox during the acute phase of TBI. As
ROS derived from gp91
phox play an important role in
primary and secondary brain damage after TBI, modula-
tion of gp91
phox in classically activated microglia and
gp91
phox-derived ROS may provide a new therapeutic
strategy in combating post-traumatic brain injury.
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